Jubilant Pharmova Ltd.
•₹ 880.351.07%
2026-08-21
PROS
- Company is almost debt free
- Latest quarter profit grew 78.0% YoY, showing strong momentum
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 5.05x)
- Working capital cycle has improved - days down from 274 to -8
- Company has a consistent dividend-paying track record
- Company generates healthy free cash flow
CONS
- Recent results are weak - TTM profit is down 85.7% versus prior year
- Company has a low return on capital employed of 2.0%
- Company has a low return on equity of 1.0% over last 3 years
- Promoter holding has decreased over last 2 years: -3.0pp
- Company's sales have been declining over the last five years
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1901.00 | 37.71 | 456113.58 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8587.00 | 77.93 | 227957.87 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 4994.90 | 87.11 | 189989.94 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1437.65 | 34.46 | 116141.01 | 0.90 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1108.80 | 24.51 | 110603.22 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2203.10 | 18.22 | 100733.42 | 0.82 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | DRREDDY | 1181.35 | 30.60 | 98604.43 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 8. | MANKIND | 2385.00 | 48.22 | 98499.54 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 9. | LAURUSLABS | 1823.00 | 90.09 | 98498.92 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1606.40 | 24.90 | 92428.71 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 412.10 | 135.59 | 67159.70 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | JUBLPHARMA | 873.60 | 39.52 | 13914.80 | 0.57 | 56.40 | -44.98 | 2229.40 | 18.65 | 8.69 | 11.12 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 204 | 179 | 170 | 202 | 53 | 61 | 56 | 60 | 60 | 66 | 67 | 70 | 67 | |
| 213 | 186 | 176 | 194 | 43 | 51 | 46 | 50 | 49 | 55 | 55 | 56 | 57 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 16 | 18 | 19 | 50 | 0 | 20 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| Interest | 6 | 7 | 8 | 8 | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 1 |
| Depreciation | 11 | 12 | 12 | 13 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| 2 | 0 | -2 | 42 | 5 | 25 | 5 | 7 | 6 | 8 | 10 | 4 | 10 | |
| Tax % | 17.39% | 300.00% | -4.35% | 21.69% | 10.20% | 41.87% | 50.94% | 86.36% | 36.92% | 664.71% | 34.65% | -1295.12% | 25.51% |
| Net Profit | 2 | -0 | -2 | 32 | 4 | 14 | 3 | 1 | 4 | -48 | 7 | 57 | 7 |
| 0 | -0 | -0 | 2 | 0 | 1 | 0 | 0 | 0 | -3 | 0 | 4 | 0 | |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 204
- 213
- Operating Profit
- —
- OPM %
- —
- Other Income
- 16
- Interest
- 6
- Depreciation
- 11
- 2
- Tax %
- 17.39%
- Net Profit
- 2
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 179
- 186
- Operating Profit
- —
- OPM %
- —
- Other Income
- 18
- Interest
- 7
- Depreciation
- 12
- 0
- Tax %
- 300.00%
- Net Profit
- -0
- -0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 170
- 176
- Operating Profit
- —
- OPM %
- —
- Other Income
- 19
- Interest
- 8
- Depreciation
- 12
- -2
- Tax %
- -4.35%
- Net Profit
- -2
- -0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 202
- 194
- Operating Profit
- —
- OPM %
- —
- Other Income
- 50
- Interest
- 8
- Depreciation
- 13
- 42
- Tax %
- 21.69%
- Net Profit
- 32
- 2
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 53
- 43
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 3
- Depreciation
- 2
- 5
- Tax %
- 10.20%
- Net Profit
- 4
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 61
- 51
- Operating Profit
- —
- OPM %
- —
- Other Income
- 20
- Interest
- 3
- Depreciation
- 2
- 25
- Tax %
- 41.87%
- Net Profit
- 14
- 1
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 56
- 46
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 3
- Depreciation
- 2
- 5
- Tax %
- 50.94%
- Net Profit
- 3
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 60
- 50
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 3
- Depreciation
- 2
- 7
- Tax %
- 86.36%
- Net Profit
- 1
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 60
- 49
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 3
- Depreciation
- 2
- 6
- Tax %
- 36.92%
- Net Profit
- 4
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 66
- 55
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 2
- 8
- Tax %
- 664.71%
- Net Profit
- -48
- -3
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 67
- 55
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 10
- Tax %
- 34.65%
- Net Profit
- 7
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 70
- 56
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 4
- Tax %
- -1295.12%
- Net Profit
- 57
- 4
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 67
- 57
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 10
- Tax %
- 25.51%
- Net Profit
- 7
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,491 | 3,306 | 3,439 | 3,140 | 2,709 | 726 | 810 | 785 | 231 | 264 | 271 | |
| 2,173 | 2,767 | 3,118 | 2,769 | 2,282 | 719 | 807 | 768 | 191 | 215 | 223 | |
| Operating Profit | 370 | 585 | 399 | 544 | 475 | 133 | 141 | 120 | 61 | 51 | — |
| OPM % | 15 | 18 | 12 | 17 | 18 | 18 | 17 | 15 | 26 | 19 | — |
| Other Income | 52 | 46 | 78 | 173 | 48 | 126 | 138 | 103 | 20 | 2 | 2 |
| Interest | 174 | 135 | 129 | 136 | 102 | 11 | 18 | 30 | 13 | 7 | 5 |
| Depreciation | 81 | 83 | 86 | 107 | 100 | 37 | 43 | 48 | 7 | 6 | 6 |
| 115 | 368 | 183 | 299 | 273 | 85 | 79 | 42 | 41 | 29 | 32 | |
| Tax % | 31 | 28 | 20 | -7 | 21 | 5 | 37 | 24 | 46 | 32 | 29 |
| Net Profit | 79 | 263 | 148 | 321 | 214 | 80 | 50 | 32 | 22 | 20 | 23 |
| EPS | 5 | 17 | 9 | 20 | 13 | 5 | 3 | 2 | 1 | 1 | — |
| Dividend Payout % | 60 | 18 | 49 | 25 | 37 | 99 | 159 | 252 | 358 | 399 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 5 | 17 | 9 | 20 | 13 | 5 | 3 | 2 | 1 | 1 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 5 | 17 | 9 | 20 | 13 | 5 | 3 | 2 | 1 | 1 | — |
Mar 2017
- 2,491
- 2,173
- Operating Profit
- 370
- OPM %
- 15
- Other Income
- 52
- Interest
- 174
- Depreciation
- 81
- 115
- Tax %
- 31
- Net Profit
- 79
- EPS
- 5
- Dividend Payout %
- 60
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2018
- 3,306
- 2,767
- Operating Profit
- 585
- OPM %
- 18
- Other Income
- 46
- Interest
- 135
- Depreciation
- 83
- 368
- Tax %
- 28
- Net Profit
- 263
- EPS
- 17
- Dividend Payout %
- 18
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
Mar 2019
- 3,439
- 3,118
- Operating Profit
- 399
- OPM %
- 12
- Other Income
- 78
- Interest
- 129
- Depreciation
- 86
- 183
- Tax %
- 20
- Net Profit
- 148
- EPS
- 9
- Dividend Payout %
- 49
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2020
- 3,140
- 2,769
- Operating Profit
- 544
- OPM %
- 17
- Other Income
- 173
- Interest
- 136
- Depreciation
- 107
- 299
- Tax %
- -7
- Net Profit
- 321
- EPS
- 20
- Dividend Payout %
- 25
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 20
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 20
Mar 2021
- 2,709
- 2,282
- Operating Profit
- 475
- OPM %
- 18
- Other Income
- 48
- Interest
- 102
- Depreciation
- 100
- 273
- Tax %
- 21
- Net Profit
- 214
- EPS
- 13
- Dividend Payout %
- 37
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
Mar 2022
- 726
- 719
- Operating Profit
- 133
- OPM %
- 18
- Other Income
- 126
- Interest
- 11
- Depreciation
- 37
- 85
- Tax %
- 5
- Net Profit
- 80
- EPS
- 5
- Dividend Payout %
- 99
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2023
- 810
- 807
- Operating Profit
- 141
- OPM %
- 17
- Other Income
- 138
- Interest
- 18
- Depreciation
- 43
- 79
- Tax %
- 37
- Net Profit
- 50
- EPS
- 3
- Dividend Payout %
- 159
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2024
- 785
- 768
- Operating Profit
- 120
- OPM %
- 15
- Other Income
- 103
- Interest
- 30
- Depreciation
- 48
- 42
- Tax %
- 24
- Net Profit
- 32
- EPS
- 2
- Dividend Payout %
- 252
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2025
- 231
- 191
- Operating Profit
- 61
- OPM %
- 26
- Other Income
- 20
- Interest
- 13
- Depreciation
- 7
- 41
- Tax %
- 46
- Net Profit
- 22
- EPS
- 1
- Dividend Payout %
- 358
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2026
- 264
- 215
- Operating Profit
- 51
- OPM %
- 19
- Other Income
- 2
- Interest
- 7
- Depreciation
- 6
- 29
- Tax %
- 32
- Net Profit
- 20
- EPS
- 1
- Dividend Payout %
- 399
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
TTM
- 271
- 223
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 5
- Depreciation
- 6
- 32
- Tax %
- 29
- Net Profit
- 23
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- -21%
- 5 Years:
- -37%
- 3 Years:
- -31%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- -1%
- 5 Years:
- -22%
- 3 Years:
- 8%
STOCK PRICE CAGR
- 10 Years:
- 6%
- 5 Years:
- 8%
- 3 Years:
- 26%
- 1 Year:
- -17%
RETURN ON EQUITY
- 10 Years:
- 6%
- 5 Years:
- 2%
- 3 Years:
- 1%
- Last Year:
- 1%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| 2,026 | 2,233 | 2,324 | 2,591 | 1,267 | 2,423 | 2,395 | 2,346 | 2,289 | 2,278 | |
| 311 | 365 | 562 | 636 | 73 | 0 | 128 | 94 | 60 | 0 | |
| Trade Payables | 487 | 749 | 596 | 619 | 16 | 159 | 164 | 148 | 155 | 9 |
| 1,542 | 1,262 | 1,365 | 1,571 | 473 | 263 | 289 | 375 | 378 | 85 | |
| Total Liabilities | 4,382 | 4,625 | 4,864 | 5,433 | 1,845 | 2,860 | 2,991 | 2,980 | 2,898 | 2,387 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 1,421 | 1,438 | 1,491 | 1,865 | 127 | 637 | 687 | 711 | 699 | 116 | |
| Capital Work in Progress | 65 | 115 | 284 | 58 | 0 | 35 | 47 | 37 | 19 | 6 |
| 1,710 | 1,706 | 1,764 | 1,764 | 1,646 | 1,646 | 1,657 | 1,657 | 1,657 | 2,176 | |
| 454 | 586 | 492 | 656 | 0 | 323 | 314 | 251 | 232 | 0 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 194 | 206 | 24 | |
| Cash & Bank | 77 | 38 | 35 | 258 | 40 | 23 | 11 | 36 | 13 | 10 |
| 655 | 742 | 798 | 832 | 31 | 197 | 276 | 94 | 72 | 56 | |
| Total Assets | 4,382 | 4,625 | 4,864 | 5,433 | 1,845 | 2,860 | 2,991 | 2,980 | 2,898 | 2,387 |
| Total Debt | 1,698 | 1,424 | 1,702 | 1,964 | 493 | 174 | 302 | 343 | 306 | 50 |
| Net Working Capital | 234 | 87 | -17 | 347 | -54 | 274 | 218 | 225 | 174 | -6 |
| Contingent Liabilities | 426 | 386 | 385 | 346 | 69 | 70 | 70 | 78 | 66 | 89 |
| Book Value per Share | 128.22 | 141.21 | 146.93 | 163.69 | 80.52 | 153.10 | 151.61 | 148.57 | 144.98 | 144.26 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 1,698 | 1,424 | 1,702 | 1,964 | 493 | 174 | 302 | 343 | 306 | 50 |
| Net Working Capital | 234 | 87 | -17 | 347 | -54 | 274 | 218 | 225 | 174 | -6 |
| Contingent Liabilities | 426 | 386 | 385 | 346 | 69 | 70 | 70 | 78 | 66 | 89 |
| Book Value per Share | 128.22 | 141.21 | 146.93 | 163.69 | 80.52 | 153.10 | 151.61 | 148.57 | 144.98 | 144.26 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2017
- Equity Capital
- 16
- 2,026
- 311
- Trade Payables
- 487
- 1,542
- Total Liabilities
- 4,382
- 1,421
- Capital Work in Progress
- 65
- 1,710
- 454
- 0
- Cash & Bank
- 77
- 655
- Total Assets
- 4,382
- Total Debt
- 1,698
- Net Working Capital
- 234
- Contingent Liabilities
- 426
- Book Value per Share
- 128.22
- Face Value
- 1.00
- Total Debt
- 1,698
- Net Working Capital
- 234
- Contingent Liabilities
- 426
- Book Value per Share
- 128.22
- Face Value
- 1.00
Mar 2018
- Equity Capital
- 16
- 2,233
- 365
- Trade Payables
- 749
- 1,262
- Total Liabilities
- 4,625
- 1,438
- Capital Work in Progress
- 115
- 1,706
- 586
- 0
- Cash & Bank
- 38
- 742
- Total Assets
- 4,625
- Total Debt
- 1,424
- Net Working Capital
- 87
- Contingent Liabilities
- 386
- Book Value per Share
- 141.21
- Face Value
- 1.00
- Total Debt
- 1,424
- Net Working Capital
- 87
- Contingent Liabilities
- 386
- Book Value per Share
- 141.21
- Face Value
- 1.00
Mar 2019
- Equity Capital
- 16
- 2,324
- 562
- Trade Payables
- 596
- 1,365
- Total Liabilities
- 4,864
- 1,491
- Capital Work in Progress
- 284
- 1,764
- 492
- 0
- Cash & Bank
- 35
- 798
- Total Assets
- 4,864
- Total Debt
- 1,702
- Net Working Capital
- -17
- Contingent Liabilities
- 385
- Book Value per Share
- 146.93
- Face Value
- 1.00
- Total Debt
- 1,702
- Net Working Capital
- -17
- Contingent Liabilities
- 385
- Book Value per Share
- 146.93
- Face Value
- 1.00
Mar 2020
- Equity Capital
- 16
- 2,591
- 636
- Trade Payables
- 619
- 1,571
- Total Liabilities
- 5,433
- 1,865
- Capital Work in Progress
- 58
- 1,764
- 656
- 0
- Cash & Bank
- 258
- 832
- Total Assets
- 5,433
- Total Debt
- 1,964
- Net Working Capital
- 347
- Contingent Liabilities
- 346
- Book Value per Share
- 163.69
- Face Value
- 1.00
- Total Debt
- 1,964
- Net Working Capital
- 347
- Contingent Liabilities
- 346
- Book Value per Share
- 163.69
- Face Value
- 1.00
Mar 2021
- Equity Capital
- 16
- 1,267
- 73
- Trade Payables
- 16
- 473
- Total Liabilities
- 1,845
- 127
- Capital Work in Progress
- 0
- 1,646
- 0
- 0
- Cash & Bank
- 40
- 31
- Total Assets
- 1,845
- Total Debt
- 493
- Net Working Capital
- -54
- Contingent Liabilities
- 69
- Book Value per Share
- 80.52
- Face Value
- 1.00
- Total Debt
- 493
- Net Working Capital
- -54
- Contingent Liabilities
- 69
- Book Value per Share
- 80.52
- Face Value
- 1.00
Mar 2022
- Equity Capital
- 16
- 2,423
- 0
- Trade Payables
- 159
- 263
- Total Liabilities
- 2,860
- 637
- Capital Work in Progress
- 35
- 1,646
- 323
- 0
- Cash & Bank
- 23
- 197
- Total Assets
- 2,860
- Total Debt
- 174
- Net Working Capital
- 274
- Contingent Liabilities
- 70
- Book Value per Share
- 153.10
- Face Value
- 1.00
- Total Debt
- 174
- Net Working Capital
- 274
- Contingent Liabilities
- 70
- Book Value per Share
- 153.10
- Face Value
- 1.00
Mar 2023
- Equity Capital
- 16
- 2,395
- 128
- Trade Payables
- 164
- 289
- Total Liabilities
- 2,991
- 687
- Capital Work in Progress
- 47
- 1,657
- 314
- 0
- Cash & Bank
- 11
- 276
- Total Assets
- 2,991
- Total Debt
- 302
- Net Working Capital
- 218
- Contingent Liabilities
- 70
- Book Value per Share
- 151.61
- Face Value
- 1.00
- Total Debt
- 302
- Net Working Capital
- 218
- Contingent Liabilities
- 70
- Book Value per Share
- 151.61
- Face Value
- 1.00
Mar 2024
- Equity Capital
- 16
- 2,346
- 94
- Trade Payables
- 148
- 375
- Total Liabilities
- 2,980
- 711
- Capital Work in Progress
- 37
- 1,657
- 251
- 194
- Cash & Bank
- 36
- 94
- Total Assets
- 2,980
- Total Debt
- 343
- Net Working Capital
- 225
- Contingent Liabilities
- 78
- Book Value per Share
- 148.57
- Face Value
- 1.00
- Total Debt
- 343
- Net Working Capital
- 225
- Contingent Liabilities
- 78
- Book Value per Share
- 148.57
- Face Value
- 1.00
Mar 2025
- Equity Capital
- 16
- 2,289
- 60
- Trade Payables
- 155
- 378
- Total Liabilities
- 2,898
- 699
- Capital Work in Progress
- 19
- 1,657
- 232
- 206
- Cash & Bank
- 13
- 72
- Total Assets
- 2,898
- Total Debt
- 306
- Net Working Capital
- 174
- Contingent Liabilities
- 66
- Book Value per Share
- 144.98
- Face Value
- 1.00
- Total Debt
- 306
- Net Working Capital
- 174
- Contingent Liabilities
- 66
- Book Value per Share
- 144.98
- Face Value
- 1.00
Mar 2026
- Equity Capital
- 16
- 2,278
- 0
- Trade Payables
- 9
- 85
- Total Liabilities
- 2,387
- 116
- Capital Work in Progress
- 6
- 2,176
- 0
- 24
- Cash & Bank
- 10
- 56
- Total Assets
- 2,387
- Total Debt
- 50
- Net Working Capital
- -6
- Contingent Liabilities
- 89
- Book Value per Share
- 144.26
- Face Value
- 1.00
- Total Debt
- 50
- Net Working Capital
- -6
- Contingent Liabilities
- 89
- Book Value per Share
- 144.26
- Face Value
- 1.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 419 | 558 | 182 | 317 | 608 | -4 | -65 | 143 | 136 | 94 | |
| Cash from Investing | -43 | -127 | -285 | -198 | 178 | 93 | 31 | -40 | -2 | 44 |
| Cash from Financing | -338 | -470 | 85 | -41 | -782 | -107 | 22 | -78 | -157 | -130 |
| 38 | -40 | -18 | 78 | 5 | -18 | -12 | 25 | -24 | 7 | |
| Free Cash Flow | 304 | 409 | -124 | 68 | 608 | -757 | -157 | 92 | 126 | 94 |
| OCF / Net Profit | 5.29 | 2.12 | 1.23 | 0.99 | 2.84 | -0.04 | -1.30 | 4.53 | 6.11 | 4.70 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 1,266 | 206 | -361 | -145 | -87 | -602 |
| OCF / Net Profit | 5.29 | 2.12 | 1.23 | 0.99 | 2.84 | -0.04 | -1.30 | 4.53 | 6.11 | 4.70 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 1,266 | 206 | -361 | -145 | -87 | -602 |
Mar 2017
- 419
- Cash from Investing
- -43
- Cash from Financing
- -338
- 38
- Free Cash Flow
- 304
- OCF / Net Profit
- 5.29
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 5.29
- Cumulative 5-Year FCF
- 0
Mar 2018
- 558
- Cash from Investing
- -127
- Cash from Financing
- -470
- -40
- Free Cash Flow
- 409
- OCF / Net Profit
- 2.12
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.12
- Cumulative 5-Year FCF
- 0
Mar 2019
- 182
- Cash from Investing
- -285
- Cash from Financing
- 85
- -18
- Free Cash Flow
- -124
- OCF / Net Profit
- 1.23
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.23
- Cumulative 5-Year FCF
- 0
Mar 2020
- 317
- Cash from Investing
- -198
- Cash from Financing
- -41
- 78
- Free Cash Flow
- 68
- OCF / Net Profit
- 0.99
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.99
- Cumulative 5-Year FCF
- 0
Mar 2021
- 608
- Cash from Investing
- 178
- Cash from Financing
- -782
- 5
- Free Cash Flow
- 608
- OCF / Net Profit
- 2.84
- Cumulative 5-Year FCF
- 1,266
- OCF / Net Profit
- 2.84
- Cumulative 5-Year FCF
- 1,266
Mar 2022
- -4
- Cash from Investing
- 93
- Cash from Financing
- -107
- -18
- Free Cash Flow
- -757
- OCF / Net Profit
- -0.04
- Cumulative 5-Year FCF
- 206
- OCF / Net Profit
- -0.04
- Cumulative 5-Year FCF
- 206
Mar 2023
- -65
- Cash from Investing
- 31
- Cash from Financing
- 22
- -12
- Free Cash Flow
- -157
- OCF / Net Profit
- -1.30
- Cumulative 5-Year FCF
- -361
- OCF / Net Profit
- -1.30
- Cumulative 5-Year FCF
- -361
Mar 2024
- 143
- Cash from Investing
- -40
- Cash from Financing
- -78
- 25
- Free Cash Flow
- 92
- OCF / Net Profit
- 4.53
- Cumulative 5-Year FCF
- -145
- OCF / Net Profit
- 4.53
- Cumulative 5-Year FCF
- -145
Mar 2025
- 136
- Cash from Investing
- -2
- Cash from Financing
- -157
- -24
- Free Cash Flow
- 126
- OCF / Net Profit
- 6.11
- Cumulative 5-Year FCF
- -87
- OCF / Net Profit
- 6.11
- Cumulative 5-Year FCF
- -87
Mar 2026
- 94
- Cash from Investing
- 44
- Cash from Financing
- -130
- 7
- Free Cash Flow
- 94
- OCF / Net Profit
- 4.70
- Cumulative 5-Year FCF
- -602
- OCF / Net Profit
- 4.70
- Cumulative 5-Year FCF
- -602
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 4.97 | 16.54 | 9.27 | 20.16 | 13.47 | 5.05 | 3.14 | 1.99 | 1.40 | 1.25 |
| Book Value (₹) | 128.22 | 141.21 | 146.93 | 163.69 | 80.52 | 153.10 | 151.61 | 148.57 | 144.98 | 144.26 |
| Dividend per Share (₹) | 3.00 | 3.00 | 4.50 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Cash EPS (₹) | 10.07 | 21.73 | 14.70 | 26.90 | 19.74 | 7.37 | 5.86 | 5.03 | 1.81 | 1.63 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 14.10% | 17.51% | 11.60% | 17.33% | 17.53% | 18.27% | 17.41% | 2.10% | 17.59% | 18.52% |
| Net Margin % | 3.02% | 7.88% | 4.29% | 10.23% | 7.92% | 11.09% | 6.16% | 4.03% | 9.59% | 7.55% |
| ROE % | 3.91% | 12.28% | 6.43% | 12.98% | 11.03% | 4.33% | 2.06% | 1.32% | 0.95% | 0.87% |
| ROCE % | 7.64% | 13.57% | 8.10% | 10.10% | 11.82% | 4.36% | 3.67% | 2.64% | 2.03% | 1.46% |
| 1.82% | 5.85% | 3.11% | 6.24% | 5.89% | 3.42% | 1.71% | 1.06% | 0.76% | 0.75% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 51 | 48 | 52 | 53 | 0 | 66 | 72 | 89 | 316 | 159 |
| Inventory Days | 65 | 57 | 57 | 67 | 0 | 163 | 143 | 131 | 381 | 0 |
| Payable Days | 119 | 127 | 120 | 132 | 80 | 96 | 142 | 161 | 0 | 0 |
| -3 | -23 | -11 | -12 | -80 | 132 | 73 | 60 | 697 | 159 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.83x | 0.63x | 0.73x | 0.75x | 0.38x | 0.07x | 0.13x | 0.15x | 0.13x | 0.02x |
| Interest Coverage (x) | 1.66x | 3.72x | 2.42x | 3.19x | 3.68x | 8.71x | 5.29x | 2.39x | 4.21x | 5.00x |
| 1.26x | 1.07x | 0.99x | 1.25x | 0.55x | 2.08x | 1.60x | 1.71x | 1.56x | 0.90x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -6.21% | 32.72% | 4.00% | -8.69% | -13.71% | -73.22% | 11.62% | -3.14% | -70.51% | 13.87% |
| Operating Profit Growth % | -1.10% | 58.27% | -31.87% | 36.42% | -12.72% | -72.08% | 6.32% | -14.96% | -49.21% | -15.93% |
| Net Profit Growth % | 8.48% | 232.65% | -43.96% | 117.53% | -33.21% | -62.47% | -38.01% | -36.67% | -29.75% | -10.36% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -36.67% | -29.75% | -10.36% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 286.05x | 639.38x | 652.33x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 3.83x | 6.16x | 5.66x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.88% | 0.56% | 0.61% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 77.95x | 237.89x | 254.32x |
Mar 2017
- EPS (₹)
- 4.97
- Book Value (₹)
- 128.22
- Dividend per Share (₹)
- 3.00
- Cash EPS (₹)
- 10.07
- Operating Margin %
- 14.10%
- Net Margin %
- 3.02%
- ROE %
- 3.91%
- ROCE %
- 7.64%
- 1.82%
- Debtor Days
- 51
- Inventory Days
- 65
- Payable Days
- 119
- -3
- Debt to Equity (x)
- 0.83x
- Interest Coverage (x)
- 1.66x
- 1.26x
- Revenue Growth %
- -6.21%
- Operating Profit Growth %
- -1.10%
- Net Profit Growth %
- 8.48%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 16.54
- Book Value (₹)
- 141.21
- Dividend per Share (₹)
- 3.00
- Cash EPS (₹)
- 21.73
- Operating Margin %
- 17.51%
- Net Margin %
- 7.88%
- ROE %
- 12.28%
- ROCE %
- 13.57%
- 5.85%
- Debtor Days
- 48
- Inventory Days
- 57
- Payable Days
- 127
- -23
- Debt to Equity (x)
- 0.63x
- Interest Coverage (x)
- 3.72x
- 1.07x
- Revenue Growth %
- 32.72%
- Operating Profit Growth %
- 58.27%
- Net Profit Growth %
- 232.65%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 9.27
- Book Value (₹)
- 146.93
- Dividend per Share (₹)
- 4.50
- Cash EPS (₹)
- 14.70
- Operating Margin %
- 11.60%
- Net Margin %
- 4.29%
- ROE %
- 6.43%
- ROCE %
- 8.10%
- 3.11%
- Debtor Days
- 52
- Inventory Days
- 57
- Payable Days
- 120
- -11
- Debt to Equity (x)
- 0.73x
- Interest Coverage (x)
- 2.42x
- 0.99x
- Revenue Growth %
- 4.00%
- Operating Profit Growth %
- -31.87%
- Net Profit Growth %
- -43.96%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 20.16
- Book Value (₹)
- 163.69
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 26.90
- Operating Margin %
- 17.33%
- Net Margin %
- 10.23%
- ROE %
- 12.98%
- ROCE %
- 10.10%
- 6.24%
- Debtor Days
- 53
- Inventory Days
- 67
- Payable Days
- 132
- -12
- Debt to Equity (x)
- 0.75x
- Interest Coverage (x)
- 3.19x
- 1.25x
- Revenue Growth %
- -8.69%
- Operating Profit Growth %
- 36.42%
- Net Profit Growth %
- 117.53%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 13.47
- Book Value (₹)
- 80.52
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 19.74
- Operating Margin %
- 17.53%
- Net Margin %
- 7.92%
- ROE %
- 11.03%
- ROCE %
- 11.82%
- 5.89%
- Debtor Days
- 0
- Inventory Days
- 0
- Payable Days
- 80
- -80
- Debt to Equity (x)
- 0.38x
- Interest Coverage (x)
- 3.68x
- 0.55x
- Revenue Growth %
- -13.71%
- Operating Profit Growth %
- -12.72%
- Net Profit Growth %
- -33.21%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 5.05
- Book Value (₹)
- 153.10
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 7.37
- Operating Margin %
- 18.27%
- Net Margin %
- 11.09%
- ROE %
- 4.33%
- ROCE %
- 4.36%
- 3.42%
- Debtor Days
- 66
- Inventory Days
- 163
- Payable Days
- 96
- 132
- Debt to Equity (x)
- 0.07x
- Interest Coverage (x)
- 8.71x
- 2.08x
- Revenue Growth %
- -73.22%
- Operating Profit Growth %
- -72.08%
- Net Profit Growth %
- -62.47%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 3.14
- Book Value (₹)
- 151.61
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 5.86
- Operating Margin %
- 17.41%
- Net Margin %
- 6.16%
- ROE %
- 2.06%
- ROCE %
- 3.67%
- 1.71%
- Debtor Days
- 72
- Inventory Days
- 143
- Payable Days
- 142
- 73
- Debt to Equity (x)
- 0.13x
- Interest Coverage (x)
- 5.29x
- 1.60x
- Revenue Growth %
- 11.62%
- Operating Profit Growth %
- 6.32%
- Net Profit Growth %
- -38.01%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 1.99
- Book Value (₹)
- 148.57
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 5.03
- Operating Margin %
- 2.10%
- Net Margin %
- 4.03%
- ROE %
- 1.32%
- ROCE %
- 2.64%
- 1.06%
- Debtor Days
- 89
- Inventory Days
- 131
- Payable Days
- 161
- 60
- Debt to Equity (x)
- 0.15x
- Interest Coverage (x)
- 2.39x
- 1.71x
- Revenue Growth %
- -3.14%
- Operating Profit Growth %
- -14.96%
- Net Profit Growth %
- -36.67%
- -36.67%
- P/E (x)
- 286.05x
- P/B (x)
- 3.83x
- Dividend Yield %
- 0.88%
- 77.95x
Mar 2025
- EPS (₹)
- 1.40
- Book Value (₹)
- 144.98
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 1.81
- Operating Margin %
- 17.59%
- Net Margin %
- 9.59%
- ROE %
- 0.95%
- ROCE %
- 2.03%
- 0.76%
- Debtor Days
- 316
- Inventory Days
- 381
- Payable Days
- 0
- 697
- Debt to Equity (x)
- 0.13x
- Interest Coverage (x)
- 4.21x
- 1.56x
- Revenue Growth %
- -70.51%
- Operating Profit Growth %
- -49.21%
- Net Profit Growth %
- -29.75%
- -29.75%
- P/E (x)
- 639.38x
- P/B (x)
- 6.16x
- Dividend Yield %
- 0.56%
- 237.89x
Mar 2026
- EPS (₹)
- 1.25
- Book Value (₹)
- 144.26
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 1.63
- Operating Margin %
- 18.52%
- Net Margin %
- 7.55%
- ROE %
- 0.87%
- ROCE %
- 1.46%
- 0.75%
- Debtor Days
- 159
- Inventory Days
- 0
- Payable Days
- 0
- 159
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 5.00x
- 0.90x
- Revenue Growth %
- 13.87%
- Operating Profit Growth %
- -15.93%
- Net Profit Growth %
- -10.36%
- -10.36%
- P/E (x)
- 652.33x
- P/B (x)
- 5.66x
- Dividend Yield %
- 0.61%
- 254.32x
Documents
Announcements
- Shareholders meeting
2026-08-17 - Jubilant Pharmova Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
- Copy of Newspaper Publication
2026-08-11 - Jubilant Pharmova Limited has informed the Exchange about Copy of Newspaper Publication
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
May 2026
Feb 2026
Oct 2025